Skip to main content
C

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,244 across all filing types
Latest filing 2023-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
关于2023年度日常关联交易预计公告
Regulatory Filings
2023-04-26 Chinese
独立董事2022年度述职报告(张继国)
Regulatory Filings
2023-04-26 Chinese
非经营性资金占用及其他关联资金往来情况的专项说明
Regulatory Filings
2023-04-26 Chinese
2022年度财务决算报告
Regulatory Filings
2023-04-26 Chinese
关于聘任高级管理人员的公告
Regulatory Filings
2023-04-10 Chinese
独立董事关于第五届董事会第二十八次会议相关事项的独立意见
Regulatory Filings
2023-04-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.